To provide a detailed answer regarding novel variants with similar effects to rs794727152, I will analyze the variant and its characteristics. Below is the information in English and Japanese:

---

### **English**

#### 1. Variant Identification:
- **rs794727152**: This is a known single nucleotide variant (SNV) in the human genome. It is associated with the **CFTR gene**, which is linked to cystic fibrosis. The HGVS notation for this variant is **NM_000492.3(CFTR):c.1521_1523delCTT (p.Phe508del)**, indicating a deletion of three nucleotides leading to the loss of phenylalanine at position 508 in the CFTR protein.
- **Transcript Name**: NM_000492.3
- **Links**: [ClinVar entry for rs794727152](https://www.ncbi.nlm.nih.gov/clinvar/variation/rs794727152)

#### 2. Disease Associations:
- **Cystic Fibrosis**: rs794727152 (p.Phe508del) is the most common pathogenic variant causing cystic fibrosis, a severe autosomal recessive disorder affecting the lungs and digestive system.
- Predictive models such as **SIFT** and **PolyPhen** classify this variant as deleterious, and it is well-documented in databases like ClinVar.

#### 3. Literature Evidence:
- This variant has been extensively studied in the context of cystic fibrosis. Key publications include:
  - Riordan JR et al., 1989: Identification of the CFTR gene and the p.Phe508del mutation ([PubMed](https://pubmed.ncbi.nlm.nih.gov/2475911/)).
  - Cutting GR, 2015: Overview of CFTR mutations and their clinical implications ([PubMed](https://pubmed.ncbi.nlm.nih.gov/25981775/)).

#### 4. Allele Frequency Comparison:
- **Global Frequency**: The p.Phe508del variant is most prevalent in European populations, with an allele frequency of approximately 70% among cystic fibrosis patients.
- **Japanese Population**: This variant is extremely rare in East Asian populations, including Japanese individuals, due to differences in genetic background.

#### 5. GWAS Findings:
- GWAS studies have not identified rs794727152 as associated with phenotypes outside of cystic fibrosis. Its effects are specific to the CFTR gene and the disease mechanism.

---

#### Novel Variants with Similar Effects:
- Variants with similar effects to rs794727152 would likely involve deletions or missense mutations in the **CFTR gene** that disrupt protein folding or function. Examples include:
  - **rs121908755 (p.Gly542X)**: A nonsense mutation leading to a truncated CFTR protein.
  - **rs121908769 (p.Arg117His)**: A missense mutation affecting CFTR channel function.

These variants are also associated with cystic fibrosis and have been studied extensively. However, novel variants may exist and could be identified through sequencing studies in diverse populations.

---

### **Japanese**

#### 1. 変異の特定:
- **rs794727152**: この変異はヒトゲノムにおける既知の一塩基変異（SNV）であり、**CFTR遺伝子**に関連しています。この変異のHGVS表記は **NM_000492.3(CFTR):c.1521_1523delCTT (p.Phe508del)** で、CFTRタンパク質の508番目のフェニルアラニンが欠失することを示しています。
- **転写産物名**: NM_000492.3
- **リンク**: [ClinVarのrs794727152エントリ](https://www.ncbi.nlm.nih.gov/clinvar/variation/rs794727152)

#### 2. 疾患との関連:
- **嚢胞性線維症**: rs794727152 (p.Phe508del) は、肺や消化器系に影響を与える重度の常染色体劣性疾患である嚢胞性線維症を引き起こす最も一般的な病原性変異です。
- **SIFT**や**PolyPhen**などの予測モデルでは、この変異を有害と分類しており、ClinVarなどのデータベースで広く文書化されています。

#### 3. 文献の証拠:
- この変異は嚢胞性線維症の文脈で広く研究されています。主な出版物には以下が含まれます：
  - Riordan JR et al., 1989: CFTR遺伝子とp.Phe508del変異の同定 ([PubMed](https://pubmed.ncbi.nlm.nih.gov/2475911/))
  - Cutting GR, 2015: CFTR変異とその臨床的影響の概要 ([PubMed](https://pubmed.ncbi.nlm.nih.gov/25981775/))

#### 4. 対立遺伝子頻度の比較:
- **世界的頻度**: p.Phe508del変異はヨーロッパ系集団で最も多く見られ、嚢胞性線維症患者の間で約70%の対立遺伝子頻度を示します。
- **日本人集団**: この変異は東アジア集団（日本人を含む）では非常に稀であり、遺伝的背景の違いによるものです。

#### 5. GWASの発見:
- GWAS研究では、rs794727152が嚢胞性線維症以外の表現型と関連していることは確認されていません。その影響はCFTR遺伝子と疾患メカニズムに特異的です。

---

#### 類似の効果を持つ新規変異:
- rs794727152と類似の効果を持つ変異は、CFTR遺伝子内でタンパク質の折り畳みや機能を損なう欠失やミスセンス変異である可能性があります。例として以下が挙げられます：
  - **rs121908755 (p.Gly542X)**: CFTRタンパク質が切断されるナンセンス変異。
  - **rs121908769 (p.Arg117His)**: CFTRチャネル機能に影響を与えるミスセンス変異。

これらの変異も嚢胞性線維症に関連しており、広く研究されています。ただし、新規変異は多様な集団でのシーケンシング研究を通じて特定される可能性があります。

--- 

If you need further clarification or additional analysis, feel free to ask!